Thomson Acquires Unleashed Informatics to Expand Pharma Service With BIND, Other Data | GenomeWeb
Information services giant Thomson has acquired tiny Unleashed Informatics in a bid to expand its content offering for pharmaceutical customers.
Financial terms of the acquisition, announced this week, were not disclosed. Privately held Unleashed’s four employees will join a company that employs more than 32,000 people worldwide and posted revenues of $6.6 billion in 2006. Unleashed will become a part of Thomson Scientific, one of Thomson’s six business units, which generated revenue of $602 million in 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.